OMIC Stock Price | Singular Genomics Systems Inc P/E, Revenue, EPS, & Forecasts

Singular Genomics Systems Inc • OMIC

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Singular Genomics Systems Inc

Ticker

OMIC

Trading on

NASDAQ

ISIN

US82933R1005

Industry

Medical Instruments & Supplies

Sector

Healthcare

CEO

Andrew Spaventa

Headquarters

3010 Science Park Road, San Diego, CA, United States, 92121

Employees

255

Website

singulargenomics.com

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. It is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. The company was incorporated in 2016 and is based in San Diego, California. As of February 21, 2025, Singular Genomics Systems, Inc. was taken private.

Metrics

BasicAdvanced

Market cap

$50.8M

P/E ratio

EPS

-$34.68

Dividend Yield

0.00%

Beta

1.84

Forward P/E ratio

EBIDTA

$-87.1M

Ex dividend date

Price & volume

Market cap

$50.8M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

19.03

Price to book

0.41

Earnings

EPS

-$34.68

EPS estimate (current quarter)

-$8.05

EPS estimate (next quarter)

-$8.01

EBITDA

$-87.1M

Revenues (TTM)

$2.7M

Revenues per share (TTM)

$1.07

Technicals

Beta

1.84

52-week High

$21.90

52-week Low

$19.00

50-day moving average

$19.77

200-day moving average

$14.35

Short ratio

4.34

Short %

2.47%

Management effectiveness

ROE (TTM)

-53.57%

ROA (TTM)

-24.21%

Profit margin

0.00%

Gross profit margin

$-1.4M

Operating margin

-4,450.99%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

-12.10%

Share stats

Outstanding Shares

2.5M

Float

1.8M

Insiders %

14.10%

Institutions %

54.81%

Analyst Insights & forecasts

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$12.45

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.32

-$0.34

5.88%

Q4 • 23Beat

-$0.34

-$0.35

2.86%

Q1 • 24Beat

-$8.57

-$0.29

-2,855.17%

Q2 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0.7M

$-21.3M

-2,883.85%

Q2 • 24

$0.4M

$-16.8M

-4,136.70%

Q3 • 24

-44.91%

-20.98%

43.44%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$220M

$82.3M

37.41%

Q2 • 24

$187M

$63.3M

33.93%

Q3 • 24

-15.21%

-23.08%

-9.29%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-18M

$24M

$0.1M

$-18M

Q2 • 24

$-19.8M

$42.3M

$0M

$-19.8M

Q3 • 24

9.70%

76.49%

-100.00%

9.73%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Singular Genomics Systems Inc share?

Singular Genomics Systems Inc shares are currently traded for undefined per share.

How many shares does Singular Genomics Systems Inc have?

Singular Genomics Systems Inc currently has 2.5M shares.

Does Singular Genomics Systems Inc pay dividends?

No, Singular Genomics Systems Inc doesn't pay dividends.

What is Singular Genomics Systems Inc 52 week high?

Singular Genomics Systems Inc 52 week high is $21.90.

What is Singular Genomics Systems Inc 52 week low?

Singular Genomics Systems Inc 52 week low is $19.00.

What is the 200-day moving average of Singular Genomics Systems Inc?

Singular Genomics Systems Inc 200-day moving average is $14.35.

Who is Singular Genomics Systems Inc CEO?

The CEO of Singular Genomics Systems Inc is Andrew Spaventa.

How many employees Singular Genomics Systems Inc has?

Singular Genomics Systems Inc has 255 employees.

What is the market cap of Singular Genomics Systems Inc?

The market cap of Singular Genomics Systems Inc is $50.8M.

What is the P/E of Singular Genomics Systems Inc?

The current P/E of Singular Genomics Systems Inc is null.

What is the EPS of Singular Genomics Systems Inc?

The EPS of Singular Genomics Systems Inc is -$34.68.

What is the PEG Ratio of Singular Genomics Systems Inc?

The PEG Ratio of Singular Genomics Systems Inc is null.

What do analysts say about Singular Genomics Systems Inc?

According to the analysts Singular Genomics Systems Inc is considered a hold.